ArticleFrontiers in pharmacology2021

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis.

Guoxu Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.